Literature DB >> 29622659

Clonal genetic evolution at relapse of favorable-risk acute myeloid leukemia with NPM1 mutation is associated with phenotypic changes and worse outcomes.

Carmen Martínez-Losada1, Juana Serrano-López2, Josefina Serrano-López1, Nelida I Noguera3,4, Eduardo Garza5, Liliana Piredda3, Serena Lavorgna3, María Antonietta Irno Consalvo3, Tiziana Ottone3, Valentina Alfonso3, Juan Ramón Peinado6, María Victoria Garcia-Ortiz7, Teresa Morales-Ruiz7, Andrés Jérez8, Ana María Hurtado8, Pau Montesinos9, José Cervera9, Esperanza Such9, Marian Ibañez9, Amparo Sempere9, Miguel Ángel Sanz9, Francesco Lo-Coco3,4, Joaquín Sánchez-García1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29622659      PMCID： PMC6119134          DOI： 10.3324/haematol.2018.188433

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  13 in total

Review 1.  Biology and relevance of human acute myeloid leukemia stem cells.

Authors:  Daniel Thomas; Ravindra Majeti
Journal:  Blood       Date:  2017-02-03       Impact factor: 22.113

2.  Multicolor Flow Cytometry and Multigene Next-Generation Sequencing Are Complementary and Highly Predictive for Relapse in Acute Myeloid Leukemia after Allogeneic Transplantation.

Authors:  Bartlomiej M Getta; Sean M Devlin; Ross L Levine; Maria E Arcila; Abhinita S Mohanty; Ahmet Zehir; Martin S Tallman; Sergio A Giralt; Mikhail Roshal
Journal:  Biol Blood Marrow Transplant       Date:  2017-03-15       Impact factor: 5.742

Review 3.  Measurable residual disease testing in acute myeloid leukaemia.

Authors:  C S Hourigan; R P Gale; N J Gormley; G J Ossenkoppele; R B Walter
Journal:  Leukemia       Date:  2017-04-07       Impact factor: 11.528

Review 4.  Biological and clinical consequences of NPM1 mutations in AML.

Authors:  E M Heath; S M Chan; M D Minden; T Murphy; L I Shlush; A D Schimmer
Journal:  Leukemia       Date:  2017-01-23       Impact factor: 11.528

5.  Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia.

Authors:  Jan Krönke; Lars Bullinger; Veronica Teleanu; Florian Tschürtz; Verena I Gaidzik; Michael W M Kühn; Frank G Rücker; Karlheinz Holzmann; Peter Paschka; Silke Kapp-Schwörer; Daniela Späth; Thomas Kindler; Marcus Schittenhelm; Jürgen Krauter; Arnold Ganser; Gudrun Göhring; Brigitte Schlegelberger; Richard F Schlenk; Hartmut Döhner; Konstanze Döhner
Journal:  Blood       Date:  2013-05-23       Impact factor: 22.113

6.  Evolution of acute myelogenous leukemia stem cell properties after treatment and progression.

Authors:  Tzu-Chieh Ho; Mark LaMere; Brett M Stevens; John M Ashton; Jason R Myers; Kristen M O'Dwyer; Jane L Liesveld; Jason H Mendler; Monica Guzman; Jennifer D Morrissette; Jianhua Zhao; Eunice S Wang; Meir Wetzler; Craig T Jordan; Michael W Becker
Journal:  Blood       Date:  2016-07-15       Impact factor: 22.113

7.  [Clinical and biological prognostic factors in relapsed acute myeloid leukemia patients].

Authors:  Manuel Yébenes-Ramírez; Josefina Serrano; Carmen Martínez-Losada; Joaquín Sánchez-García
Journal:  Med Clin (Barc)       Date:  2016-06-30       Impact factor: 1.725

8.  Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing.

Authors:  Li Ding; Timothy J Ley; David E Larson; Christopher A Miller; Daniel C Koboldt; John S Welch; Julie K Ritchey; Margaret A Young; Tamara Lamprecht; Michael D McLellan; Joshua F McMichael; John W Wallis; Charles Lu; Dong Shen; Christopher C Harris; David J Dooling; Robert S Fulton; Lucinda L Fulton; Ken Chen; Heather Schmidt; Joelle Kalicki-Veizer; Vincent J Magrini; Lisa Cook; Sean D McGrath; Tammi L Vickery; Michael C Wendl; Sharon Heath; Mark A Watson; Daniel C Link; Michael H Tomasson; William D Shannon; Jacqueline E Payton; Shashikant Kulkarni; Peter Westervelt; Matthew J Walter; Timothy A Graubert; Elaine R Mardis; Richard K Wilson; John F DiPersio
Journal:  Nature       Date:  2012-01-11       Impact factor: 49.962

9.  Somatic mutational landscape of AML with inv(16) or t(8;21) identifies patterns of clonal evolution in relapse leukemia.

Authors:  R Sood; N F Hansen; F X Donovan; B Carrington; D Bucci; B Maskeri; A Young; N S Trivedi; J Kohlschmidt; R M Stone; M A Caligiuri; S C Chandrasekharappa; G Marcucci; J C Mullikin; C D Bloomfield; P Liu
Journal:  Leukemia       Date:  2015-06-15       Impact factor: 11.528

10.  High-Dimensional Analysis of Acute Myeloid Leukemia Reveals Phenotypic Changes in Persistent Cells during Induction Therapy.

Authors:  Paul Brent Ferrell; Kirsten Elizabeth Diggins; Hannah Grace Polikowsky; Sanjay Ram Mohan; Adam C Seegmiller; Jonathan Michael Irish
Journal:  PLoS One       Date:  2016-04-13       Impact factor: 3.240
View more
  5 in total

1.  MRD evaluation of AML in clinical practice: are we there yet?

Authors:  Sylvie D Freeman; Christopher S Hourigan
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

2.  Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing.

Authors:  Jae-Sook Ahn; TaeHyung Kim; Sung-Hoon Jung; Seo-Yeon Ahn; Seung-Yeon Jung; Ga-Young Song; Mihee Kim; Deok-Hwan Yang; Je-Jung Lee; SeungHyun Choi; Ja-Yeon Lee; Seong-Kyu Park; Joon Ho Moon; Hui Young Lee; Kyoung Ha Kim; Yu Cai; Seong Yoon Yi; Igor Novitzky-Basso; Zhaolei Zhang; Hyeoung-Joon Kim; Dennis Dong Hwan Kim
Journal:  Bone Marrow Transplant       Date:  2020-12-05       Impact factor: 5.483

Review 3.  Minimal/Measurable Residual Disease Monitoring in NPM1-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives.

Authors:  Fabio Forghieri; Patrizia Comoli; Roberto Marasca; Leonardo Potenza; Mario Luppi
Journal:  Int J Mol Sci       Date:  2018-11-06       Impact factor: 5.923

Review 4.  NPM1 Mutated, BCR-ABL1 Positive Myeloid Neoplasms: Review of the Literature.

Authors:  Gianfranco Catalano; Pasquale Niscola; Cristina Banella; Daniela Diverio; Malgorzata Monika Trawinska; Stefano Fratoni; Rita Iazzoni; Paolo De Fabritiis; Elisabetta Abruzzese; Nelida Ines Noguera
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-11-01       Impact factor: 2.576

Review 5.  The Role of Nucleophosmin 1 (NPM1) Mutation in the Diagnosis and Management of Myeloid Neoplasms.

Authors:  Katalin Kelemen
Journal:  Life (Basel)       Date:  2022-01-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.